Cargando…

Molecular Mechanisms Underlying Hepatocellular Carcinoma

Hepatocarcinogenesis is a complex process that remains still partly understood. That might be explained by the multiplicity of etiologic factors, the genetic/epigenetic heterogeneity of tumors bulks and the ignorance of the liver cell types that give rise to tumorigenic cells that have stem cell-lik...

Descripción completa

Detalles Bibliográficos
Autores principales: Merle, Philippe, Trepo, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185529/
https://www.ncbi.nlm.nih.gov/pubmed/21994573
http://dx.doi.org/10.3390/v1030852
_version_ 1782213226060054528
author Merle, Philippe
Trepo, Christian
author_facet Merle, Philippe
Trepo, Christian
author_sort Merle, Philippe
collection PubMed
description Hepatocarcinogenesis is a complex process that remains still partly understood. That might be explained by the multiplicity of etiologic factors, the genetic/epigenetic heterogeneity of tumors bulks and the ignorance of the liver cell types that give rise to tumorigenic cells that have stem cell-like properties. The DNA stress induced by hepatocyte turnover, inflammation and maybe early oncogenic pathway activation and sometimes viral factors, leads to DNA damage response which activates the key tumor suppressive checkpoints p53/p21(Cip1) and p16(INK4a)/pRb responsible of cell cycle arrest and cellular senescence as reflected by the cirrhosis stage. Still obscure mechanisms, but maybe involving the Wnt signaling and Twist proteins, would allow pre-senescent hepatocytes to bypass senescence, acquire immortality by telomerase reactivation and get the last genetic/epigenetic hits necessary for cancerous transformation. Among some of the oncogenic pathways that might play key driving roles in hepatocarcinogenesis, c-myc and the Wnt/β-catenin signaling seem of particular interest. Finally, antiproliferative and apoptosis deficiencies involving TGF-β, Akt/PTEN, IGF2 pathways for instance are prerequisite for cancerous transformation. Of evidence, not only the transformed liver cell per se but the facilitating microenvironment is of fundamental importance for tumor bulk growth and metastasis.
format Online
Article
Text
id pubmed-3185529
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-31855292011-10-12 Molecular Mechanisms Underlying Hepatocellular Carcinoma Merle, Philippe Trepo, Christian Viruses Review Hepatocarcinogenesis is a complex process that remains still partly understood. That might be explained by the multiplicity of etiologic factors, the genetic/epigenetic heterogeneity of tumors bulks and the ignorance of the liver cell types that give rise to tumorigenic cells that have stem cell-like properties. The DNA stress induced by hepatocyte turnover, inflammation and maybe early oncogenic pathway activation and sometimes viral factors, leads to DNA damage response which activates the key tumor suppressive checkpoints p53/p21(Cip1) and p16(INK4a)/pRb responsible of cell cycle arrest and cellular senescence as reflected by the cirrhosis stage. Still obscure mechanisms, but maybe involving the Wnt signaling and Twist proteins, would allow pre-senescent hepatocytes to bypass senescence, acquire immortality by telomerase reactivation and get the last genetic/epigenetic hits necessary for cancerous transformation. Among some of the oncogenic pathways that might play key driving roles in hepatocarcinogenesis, c-myc and the Wnt/β-catenin signaling seem of particular interest. Finally, antiproliferative and apoptosis deficiencies involving TGF-β, Akt/PTEN, IGF2 pathways for instance are prerequisite for cancerous transformation. Of evidence, not only the transformed liver cell per se but the facilitating microenvironment is of fundamental importance for tumor bulk growth and metastasis. Molecular Diversity Preservation International (MDPI) 2009-11-09 /pmc/articles/PMC3185529/ /pubmed/21994573 http://dx.doi.org/10.3390/v1030852 Text en © 2009 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Merle, Philippe
Trepo, Christian
Molecular Mechanisms Underlying Hepatocellular Carcinoma
title Molecular Mechanisms Underlying Hepatocellular Carcinoma
title_full Molecular Mechanisms Underlying Hepatocellular Carcinoma
title_fullStr Molecular Mechanisms Underlying Hepatocellular Carcinoma
title_full_unstemmed Molecular Mechanisms Underlying Hepatocellular Carcinoma
title_short Molecular Mechanisms Underlying Hepatocellular Carcinoma
title_sort molecular mechanisms underlying hepatocellular carcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185529/
https://www.ncbi.nlm.nih.gov/pubmed/21994573
http://dx.doi.org/10.3390/v1030852
work_keys_str_mv AT merlephilippe molecularmechanismsunderlyinghepatocellularcarcinoma
AT trepochristian molecularmechanismsunderlyinghepatocellularcarcinoma